openPR Logo
Press release

ADC Contract Manufacturing Market Set to Soar, Reaching USD 6.8 Billion by 2035

05-16-2025 01:11 PM CET | Health & Medicine

Press release from: Roots Analysis

ADC Contract Manufacturing Market Set to Soar, Reaching USD 6.8

In the fast-evolving world of biopharmaceuticals, the demand for precision and innovation has never been higher. Nowhere is this more evident than in the rapidly expanding market for Antibody-Drug Conjugate (ADC) contract manufacturing. According to a comprehensive new report from Roots Analysis, the global ADC contract manufacturing market is poised for remarkable growth-projected to surge from USD 1.79 billion in 2024 to over USD 6.8 billion by 2035, at a compound annual growth rate (CAGR) of 13%.

A Personal Glimpse into the ADC Revolution

Imagine a world where cancer treatments are not only more effective but also safer, targeting tumors with pinpoint accuracy while sparing healthy cells. That's the promise of ADCs-a class of therapies that combine the specificity of antibodies with the potency of cytotoxic drugs. But as a friend in the industry once told me, "Making these therapies isn't just science-it's an art." The complexity of ADC manufacturing, from antibody production to the delicate process of linking potent payloads, means that even the most experienced biotech firms are turning to specialized contract manufacturers to bring these life-saving drugs to market.

To request quote of this report, please visit:
https://www.rootsanalysis.com/reports/adc-contract-manufacturing-market/request-quote.html

Why the Market Is Booming

The surge in demand for ADC contract manufacturing is driven by several key factors:
1. Growing Pipeline of ADC Therapeutics: With more than 47% of ADCs currently in discovery or preclinical stages, the pipeline is expanding rapidly. This means more opportunities-and more challenges-for manufacturers.
2. Complex Manufacturing Processes: ADCs require specialized expertise in antibody production, high-potency active pharmaceutical ingredients (HPAPIs), conjugation, and final drug formulation. Each step demands state-of-the-art facilities and rigorous quality control.
3. Outsourcing Trends: As biotech companies focus on innovation, they're increasingly outsourcing manufacturing to contract development and manufacturing organizations (CDMOs) with proven track records.

Who's Leading the Charge?

The ADC contract manufacturing landscape is both competitive and collaborative, featuring around 30 key players. Over 45% of these contract manufacturers were established before 2000, bringing decades of experience to the table. Notably, half of the market's facilities are based in North America, with Switzerland emerging as a European hub. Companies like Lonza, MilliporeSigma, and WuXi Biologics are at the forefront, offering end-to-end services that cover everything from early-stage development to commercial-scale production.

A Real-World Example: WuXi Biologics and Mabwell Therapeutics

In September 2023, WuXi Biologics inked a strategic partnership with Mabwell Therapeutics to accelerate the development and commercialization of ADCs. This kind of collaboration is becoming the norm, as companies pool resources and expertise to overcome the technical hurdles of ADC manufacturing.

To request a sample copy / brochure of this report, please visit
https://www.rootsanalysis.com/reports/adc-contract-manufacturing-market/request-sample.html

Market Segmentation: A Closer Look

Roots Analysis breaks down the ADC contract manufacturing market into several key segments:

1. Stage of Development: Phase I, Phase II, Phase III, and Commercial
2. Process Component: Antibody, HPAPI/Cytotoxic Payload, Conjugation/Linker, Fill/Finish
3. Target Indication: Solid Tumors, Hematological Tumors, Others
4. Antibody Generation: Second, Third, Fourth, and Next Generation
5. Geographical Regions: North America, Europe, Asia-Pacific, and Rest of the World

Regional Insights: Where the Action Is

North America, led by the US, is expected to maintain its dominant market share through 2035. Europe is also seeing strong growth, thanks to rising demand for ADC therapies and a concentration of specialized manufacturers in Switzerland. Meanwhile, Asia-Pacific is emerging as a hotspot, driven by increasing cancer prevalence and the rapid expansion of local contract manufacturers.

Key Takeaways for Stakeholders
1. Expansion Opportunities: With 75% of manufacturing agreements focused on clinical and commercial production, there's ample room for growth across all stages of development.
2. Diverse Applications: The market is well-distributed across various target indications, antibody generations, and origins, offering multiple avenues for innovation.
3. Strategic Partnerships: Collaborations between biotech firms and contract manufacturers are becoming essential for navigating the complexities of ADC production.

Browse Full Report Description + Research Methodology + Table of Content + Infographics here:
https://www.rootsanalysis.com/reports/adc-contract-manufacturing-market/218.html

Looking Ahead

As the ADC contract manufacturing market continues to expand, companies that invest in advanced technologies, forge strategic partnerships, and maintain rigorous quality standards will be best positioned to succeed. For patients, this means faster access to cutting-edge therapies that could transform the treatment of cancer and other serious diseases.

Roots Analysis
Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
Gaurav.chaudhary@rootsanalysis.com
Website: https://www.rootsanalysis.com/

Roots Analysis is a global leader in market research, competitive intelligence and consulting services across industries. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, and venture and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serving our clients in the best possible way.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release ADC Contract Manufacturing Market Set to Soar, Reaching USD 6.8 Billion by 2035 here

News-ID: 4020557 • Views:

More Releases from Roots Analysis

Plant-Based Meat Market Set to Soar: Roots Analysis Forecasts Explosive Growth by 2035
Plant-Based Meat Market Set to Soar: Roots Analysis Forecasts Explosive Growth b …
In a world where dinner tables are increasingly filled with burgers that sizzle but don't come from cows, and nuggets that never saw a chicken coop, the plant-based meat market is making headlines. According to a new report from Roots Analysis, this sector is poised for a remarkable transformation, with the global market expected to balloon from USD 17.1 billion in 2024 to a staggering USD 54.8 billion by 2035-growing
DNA Data Storage Market Set for Explosive Growth, Says Roots Analysis
DNA Data Storage Market Set for Explosive Growth, Says Roots Analysis
Imagine a world where the entire contents of the Library of Congress could fit into a drop of liquid-and last for thousands of years. That's the promise of DNA data storage, a technology that's rapidly moving from science fiction to reality. According to a new report from Roots Analysis, the DNA data storage market is poised for dramatic expansion, with a projected compound annual growth rate (CAGR) of 28% through
Rare Kidney Disease Market Set to Surge, Fueled by Innovation and Investment
Rare Kidney Disease Market Set to Surge, Fueled by Innovation and Investment
Imagine a world where a rare diagnosis no longer means limited treatment options. For patients grappling with rare kidney diseases-conditions often overlooked in mainstream medicine-that future is closer than ever. According to a comprehensive new report from Roots Analysis, the rare kidney disease market is poised for remarkable growth, driven by scientific breakthroughs, robust investment, and a wave of new therapies entering clinical trials. To request quote of this report, please
Manufacturing Execution System Market Set to Soar to $20.46 Billion by 2035
Manufacturing Execution System Market Set to Soar to $20.46 Billion by 2035
The manufacturing world is on the brink of a technological revolution, and at the heart of this transformation lies the Manufacturing Execution System (MES) market. According to a comprehensive new report by Roots Analysis, the global MES market is expected to skyrocket from a valuation of USD 3.99 billion in 2024 to an impressive USD 20.46 billion by 2035, growing at a robust compound annual growth rate (CAGR) of 16.02%.

All 5 Releases


More Releases for ADC

Latest Azodicarbonamide (ADC) Market 2022 | Detailed Report
The market report delivers an all-inclusive analysis of the market structure along with a forecast of the various segments and sub-segments of the Azodicarbonamide (ADC) industry. This wide-ranging market research report acts as a backbone for the success of business in any niche. The Azodicarbonamide (ADC) market survey report has been prepared by conducting market research in a systematic manner. Moreover, the Azodicarbonamide (ADC) report includes a professional in-depth study
Global ADC Blowing Agents Market Analysis by 2020-2025
Global Info Research offers a latest published report on ADC Blowing Agents Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global ADC Blowing Agents Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. Click to view the full report TOC, figure
ADC Blowing Agents Market Demand by 2025: QY Research
Global ADC Blowing Agents market report is first of its kind research report that covers the overview, summary, market dynamics, competitive analysis, and leading player’s various strategies to sustain in the global market. This report covers five top regions of the globe and countries within, which shows the status of regional development, consisting of market value, volume, size, and price data. Apart from this, the report also covers detail information about
Global Data Converters Market Report 2017 (Analog to Digital Converter, Current …
The research report titled Global Data Converters Sales Market Report 2017 market size and forecast and overview on current market trends. This report studies sales (consumption) of Global Data Converters Market 2017, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering National Semiconductor Nippon Precision Circuits Inc Micro Analog systems Microchip Technology. TelCom Semiconductor, Inc Vishay Siliconix Texas
SMi’s inaugural ADC Summit, 23rd & 24th May 2012, London
Antibody Drug Conjugates are used to fight cancerous cells and are made up of the antibody that will target a specific tumour0-associated antigen a drug often described as payload and the linker. This results in a drug being delivered selectively to the appropriate malignant cell due to the antibody targeting and specific antigen With less than a month away, join SMi at their inaugural ADC Summit conference that will provide a
ADC African Development Corporation GmbH & Co. KGaA: ADC exits shareholding in E …
ADC African Development Corporation (ADC), ISIN DE000A1E8NW9, a fast growing financial services group focusing on the frontier markets of sub-Saharan Africa, has successfully negotiated an exit for its 11.5% shareholding in Ecobank Zimbabwe for USD 5.2 million equaling approx. EUR 4.0 million. As of 30 September 2011, ADC had valued its shareholding in Ecobank Zimbabwe at EUR 1.25 million, so this transaction results in a realized profit of EUR 2.75